Search research articles
Contact Us
Filters
Showing results (11-20 of 40) with videos related to
Page
of 4
Sort By:
The Journal of Rheumatology
|
September 1, 2004
Dating the "window of therapeutic opportunity" in early rheumatoid arthritis: accuracy of patient recall of arthritis symptom onset
Sogol Amjadi, Sogol Amjadi-Begvand, Dinesh Khanna, et al.
Statistical Methods in Medical Research
|
March 7, 2007
Classifying radiographic progression status in early rheumatoid arthritis patients using propensity scores to adjust for baseline differences
Grace S Park, Weng Kee Wong, MyungShin Oh, et al.
Annals of the Rheumatic Diseases
|
October 15, 2011
Predicting low disease activity and remission using early treatment response to antitumour necrosis factor therapy in patients with rheumatoid arthritis: exploratory analyses from the TEMPO trial
Jeffrey R Curtis, Shuo Yang, Lang Chen, et al.
The Journal of Rheumatology
|
April 3, 2003
Correlation of single time-point damage scores with observed progression of radiographic damage during the first 6 years of rheumatoid arthritis
Harold E Paulus, Myungshin Oh, John T Sharp, et al.
Arthritis and Rheumatism
|
April 13, 2004
Classifying structural joint damage in rheumatoid arthritis as progressive or nonprogressive using a composite definition of joint radiographic change: a preliminary proposal
Harold E Paulus, MyungShin Oh, John T Sharp, et al.
Hemodialysis International. International Symposium on Home Hemodialysis
|
August 24, 2013
TSAT is a better predictor than ferritin of hemoglobin response to Epoetin alfa in US dialysis patients
Adam E Gaweda, Premila Bhat, Gregory A Maglinte, et al.
Clinical Rheumatology
|
December 11, 2017
Defining and characterizing sustained remission in patients with rheumatoid arthritis
Jeffrey R Curtis, Mona Trivedi, Boulos Haraoui, et al.
Leukemia Research Reports
|
December 18, 2024
Management of hemolytic transfusion reactions in a patient with chronic myelomonocytic leukemia and rare antibodies: A case report
Grace S Park, Himachandana Atluri, Courtney D DiNardo, et al.
Hepatology Communications
|
January 29, 2024
Phase 2, open-label, rollover study of cenicriviroc for liver fibrosis associated with metabolic dysfunction-associated steatohepatitis
Sven M Francque, Alexander Hodge, Jerome Boursier, et al.
Arthritis and Rheumatism
|
February 1, 2006
Risk genotypes in folate-dependent enzymes and their association with methotrexate-related side effects in rheumatoid arthritis
Michael H Weisman, Daniel E Furst, Grace S Park, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 40) with videos related to
Sort By:
Page
of 4
The Journal of Rheumatology
|
September 1, 2004
Dating the "window of therapeutic opportunity" in early rheumatoid arthritis: accuracy of patient recall of arthritis symptom onset
Sogol Amjadi, Sogol Amjadi-Begvand, Dinesh Khanna, et al.
Statistical Methods in Medical Research
|
March 7, 2007
Classifying radiographic progression status in early rheumatoid arthritis patients using propensity scores to adjust for baseline differences
Grace S Park, Weng Kee Wong, MyungShin Oh, et al.
Annals of the Rheumatic Diseases
|
October 15, 2011
Predicting low disease activity and remission using early treatment response to antitumour necrosis factor therapy in patients with rheumatoid arthritis: exploratory analyses from the TEMPO trial
Jeffrey R Curtis, Shuo Yang, Lang Chen, et al.
The Journal of Rheumatology
|
April 3, 2003
Correlation of single time-point damage scores with observed progression of radiographic damage during the first 6 years of rheumatoid arthritis
Harold E Paulus, Myungshin Oh, John T Sharp, et al.
Arthritis and Rheumatism
|
April 13, 2004
Classifying structural joint damage in rheumatoid arthritis as progressive or nonprogressive using a composite definition of joint radiographic change: a preliminary proposal
Harold E Paulus, MyungShin Oh, John T Sharp, et al.
Hemodialysis International. International Symposium on Home Hemodialysis
|
August 24, 2013
TSAT is a better predictor than ferritin of hemoglobin response to Epoetin alfa in US dialysis patients
Adam E Gaweda, Premila Bhat, Gregory A Maglinte, et al.
Clinical Rheumatology
|
December 11, 2017
Defining and characterizing sustained remission in patients with rheumatoid arthritis
Jeffrey R Curtis, Mona Trivedi, Boulos Haraoui, et al.
Leukemia Research Reports
|
December 18, 2024
Management of hemolytic transfusion reactions in a patient with chronic myelomonocytic leukemia and rare antibodies: A case report
Grace S Park, Himachandana Atluri, Courtney D DiNardo, et al.
Hepatology Communications
|
January 29, 2024
Phase 2, open-label, rollover study of cenicriviroc for liver fibrosis associated with metabolic dysfunction-associated steatohepatitis
Sven M Francque, Alexander Hodge, Jerome Boursier, et al.
Arthritis and Rheumatism
|
February 1, 2006
Risk genotypes in folate-dependent enzymes and their association with methotrexate-related side effects in rheumatoid arthritis
Michael H Weisman, Daniel E Furst, Grace S Park, et al.
Page
of 4